相似文献
1
The long non-coding RNA SPRY4-IT1: An emerging player in tumorigenesis and osteosarcoma.
Cell Prolif. 2018 Aug;51(4):e12446. doi: 10.1111/cpr.12446. Epub 2018 Feb 27.
2
The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression.
Mol Cancer. 2015 Feb 22;14:51. doi: 10.1186/s12943-015-0318-0.
3
Knockdown of SPRY4 and SPRY4-IT1 inhibits cell growth and phosphorylation of Akt in human testicular germ cell tumours.
Sci Rep. 2018 Feb 6;8(1):2462. doi: 10.1038/s41598-018-20846-8.
4
Long Non-Coding RNA SPRY4-IT1 Can Predict Poor Prognosis in Digestive System Malignancies: a Meta-Analysis.
Pathol Oncol Res. 2019 Jan;25(1):89-95. doi: 10.1007/s12253-017-0327-y. Epub 2017 Sep 30.
5
Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
Biomed Pharmacother. 2017 Apr;88:529-534. doi: 10.1016/j.biopha.2017.01.037. Epub 2017 Jan 24.
6
EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
Cell Death Dis. 2014 Jun 26;5(6):e1298. doi: 10.1038/cddis.2014.256.
7
High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Int J Clin Exp Pathol. 2014 Aug 15;7(9):5801-9. eCollection 2014.
8
Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
J Transl Med. 2015 Aug 4;13:250. doi: 10.1186/s12967-015-0595-9.
9
Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Int J Clin Exp Pathol. 2015 Feb 1;8(2):1954-60. eCollection 2015.
10
SPRY4-IT1: A novel oncogenic long non-coding RNA in human cancers.
Tumour Biol. 2017 Jun;39(6):1010428317711406. doi: 10.1177/1010428317711406.
引用本文的文献
1
LncRNAs as potential prognosis/diagnosis markers and factors driving drug resistance of osteosarcoma, a review.
Front Endocrinol (Lausanne). 2024 Jul 2;15:1415722. doi: 10.3389/fendo.2024.1415722. eCollection 2024.
2
Advancements in Understanding the Role of Circular RNA in Osteosarcoma.
Mol Biotechnol. 2024 Sep;66(9):2157-2167. doi: 10.1007/s12033-023-00838-4. Epub 2023 Sep 3.
3
LncRNA SPRY4‑IT1 is upregulated and promotes the proliferation of prostate cancer cells under hypoxia in vitro.
Oncol Lett. 2023 Feb 17;25(4):138. doi: 10.3892/ol.2023.13724. eCollection 2023 Apr.
4
Long non-coding RNA DUXAP10 exerts oncogenic properties in osteosarcoma by recruiting HuR to enhance SOX18 mRNA stability.
Hum Cell. 2022 Nov;35(6):1939-1951. doi: 10.1007/s13577-022-00772-8. Epub 2022 Sep 2.
5
lncRNA DARS-AS1 Promoted Osteosarcoma Progression through Regulating miR-532-3p/CCR7.
Dis Markers. 2022 Apr 5;2022:4660217. doi: 10.1155/2022/4660217. eCollection 2022.
6
Emerging Roles of Long Non-Coding RNAs in Ankylosing Spondylitis.
Front Immunol. 2022 Feb 10;13:790924. doi: 10.3389/fimmu.2022.790924. eCollection 2022.
7
Oncogenic lncRNA ZNFX1 antisense RNA 1 promotes osteosarcoma cells proliferation and metastasis by stabilizing serine and arginine‑rich splicing factor 3.
Bioengineered. 2022 Mar;13(3):5962-5974. doi: 10.1080/21655979.2022.2036900.
8
Long noncoding RNA ADIRF antisense RNA 1 upregulates insulin receptor substrate 1 to decrease the aggressiveness of osteosarcoma by sponging microRNA-761.
Bioengineered. 2022 Feb;13(2):2028-2043. doi: 10.1080/21655979.2021.2019872.
9
LncRNA BCRT1 facilitates osteosarcoma progression via regulating miR-1303/FGF7 axis.
Aging (Albany NY). 2021 Jun 8;13(11):15501-15510. doi: 10.18632/aging.203106.
10
MSC-AS1 induced cell growth and inflammatory mediators secretion through sponging miR-142-5p/DDX5 in gastric carcinoma.
Aging (Albany NY). 2021 Apr 4;13(7):10387-10395. doi: 10.18632/aging.202800.
本文引用的文献
1
Synthesis of an ethyleneimine/tetrahedral DNA nanostructure complex and its potential application as a multi-functional delivery vehicle.
Nanoscale. 2017 Nov 30;9(46):18402-18412. doi: 10.1039/c7nr07130b.
2
Up-regulation of long non-coding RNA promotes tumor cell migration and invasion in lung adenocarcinoma.
Oncotarget. 2017 Apr 7;8(31):51058-51065. doi: 10.18632/oncotarget.16918. eCollection 2017 Aug 1.
3
The long noncoding RNA acts as an intranuclear organizing hub for pre-mRNA molecules.
Sci Adv. 2017 May 3;3(5):e1602505. doi: 10.1126/sciadv.1602505. eCollection 2017 May.
4
LINC00152: A pivotal oncogenic long non-coding RNA in human cancers.
Cell Prolif. 2017 Aug;50(4). doi: 10.1111/cpr.12349. Epub 2017 May 2.
5
Effects of long non-coding RNA SPRY4-IT1 on osteosarcoma cell biological behavior.
Am J Transl Res. 2016 Dec 15;8(12):5330-5337. eCollection 2016.
6
Long non-coding RNA CASC2 suppresses the proliferation of gastric cancer cells by regulating the MAPK signaling pathway.
Am J Transl Res. 2016 Aug 15;8(8):3522-9. eCollection 2016.
7
Upregulation of lncRNA HNF1A-AS1 promotes cell proliferation and metastasis in osteosarcoma through activation of the Wnt/β-catenin signaling pathway.
Am J Transl Res. 2016 Aug 15;8(8):3503-12. eCollection 2016.
8
ANRIL is associated with the survival rate of patients with colorectal cancer, and affects cell migration and invasion in vitro.
Mol Med Rep. 2016 Aug;14(2):1714-20. doi: 10.3892/mmr.2016.5409. Epub 2016 Jun 17.
9
CCAT1: a pivotal oncogenic long non-coding RNA in human cancers.
Cell Prolif. 2016 Jun;49(3):255-60. doi: 10.1111/cpr.12252. Epub 2016 May 1.
10
Long noncoding RNA SPRY4-IT1 promotes esophageal squamous cell carcinoma cell proliferation, invasion, and epithelial-mesenchymal transition.
Tumour Biol. 2016 Aug;37(8):10871-6. doi: 10.1007/s13277-016-4962-9. Epub 2016 Feb 16.
Zotero 插件